Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finn

Showing results (371-380 of 407) with videos related to

Pageof 41
Sort By:
Cancer Immunology Research|December 14, 2019
Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon CancerMichael Kvorjak, Yasmine Ahmed, Michelle L Miller, et al.
Frontiers in Immunology|October 25, 2024
Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer preventionCheryl M Cameron, Vineet Raghu, Brian Richardson, et al.
Scandinavian Journal of Immunology|July 1, 1997
Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulationC M Böhm, M C Mulder, R Zennadi, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer preventionCheryl M Cameron, Vineet Raghu, Brian Richardson, et al.
Proteins|April 9, 2019
The uncharacterized bacterial protein YejG has the same architecture as domain III of elongation factor GBiswaranjan Mohanty, Paulina Hanson-Manful, Thomas J Finn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinomaR S Metzgar, N Rodriguez, O J Finn, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|November 21, 2007
Facial aesthetics: achieving the natural, relaxed lookAlastair Carruthers, Joel L Cohen, Sue Ellen Cox, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2004
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancerRamesh K Ramanathan, Kenneth M Lee, John McKolanis, et al.
Transplantation Direct|September 24, 2021
Comanagement With Nephrologist Care Is Associated With Fewer Cardiovascular Events Among Liver Transplant Recipients With Chronic Kidney DiseasePatrick T Campbell, Megan Kosirog, Blessing Aghaulor, et al.
Cancer Therapy|January 9, 2009
A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumorsAndrew J Lepisto, Arthur J Moser, Herbert Zeh, et al.
Pageof 41

Showing results (371-380 of 407) with videos related to

Sort By:
Pageof 41
Cancer Immunology Research|December 14, 2019
Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon CancerMichael Kvorjak, Yasmine Ahmed, Michelle L Miller, et al.
Frontiers in Immunology|October 25, 2024
Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer preventionCheryl M Cameron, Vineet Raghu, Brian Richardson, et al.
Scandinavian Journal of Immunology|July 1, 1997
Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T cell subpopulationC M Böhm, M C Mulder, R Zennadi, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer preventionCheryl M Cameron, Vineet Raghu, Brian Richardson, et al.
Proteins|April 9, 2019
The uncharacterized bacterial protein YejG has the same architecture as domain III of elongation factor GBiswaranjan Mohanty, Paulina Hanson-Manful, Thomas J Finn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinomaR S Metzgar, N Rodriguez, O J Finn, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|November 21, 2007
Facial aesthetics: achieving the natural, relaxed lookAlastair Carruthers, Joel L Cohen, Sue Ellen Cox, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2004
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancerRamesh K Ramanathan, Kenneth M Lee, John McKolanis, et al.
Transplantation Direct|September 24, 2021
Comanagement With Nephrologist Care Is Associated With Fewer Cardiovascular Events Among Liver Transplant Recipients With Chronic Kidney DiseasePatrick T Campbell, Megan Kosirog, Blessing Aghaulor, et al.
Cancer Therapy|January 9, 2009
A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumorsAndrew J Lepisto, Arthur J Moser, Herbert Zeh, et al.
Pageof 41